๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Treatment of metastatic malignant melanoma with vinblastine, bleomycin by infusion and cisplatin

โœ Scribed by R. Martin York; David H. Lawson; Jeanine McKay

Publisher
John Wiley and Sons
Year
1983
Tongue
English
Weight
256 KB
Volume
52
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Germ cell malignancies of the ovary. Tre
Germ cell malignancies of the ovary. Treatment with vinblastine, actinomycin D, bleomycin and cisplatin containing chemotherapy combinations
โœ James E. Bradof; Dr. Thomas B. Hakes; Manuel Ochoa; Robert Golbey ๐Ÿ“‚ Article ๐Ÿ“… 1982 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 465 KB ๐Ÿ‘ 2 views

Seventeen patients with malignant ovarian germ cell tumors were treated with vinblastine, actinomycin D, bleomycin and cisplatin containing combinations. Many of these patients were heavily pretreated. Thirteen patients had objectively measurable disease and ten (77%) had an objective response (CR o

Treatment of metastatic melanoma by 24-h
Treatment of metastatic melanoma by 24-hour DTIC infusions and hemibody irradiation
โœ Nick Thatcher; Heather Anderson; Roger James; Peter Davenport; Peter Craig ๐Ÿ“‚ Article ๐Ÿ“… 1986 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 410 KB ๐Ÿ‘ 1 views

Forty-three patients with widely metastatic melanoma were studied. Visceral metastases were present in 79% of the patient group, including five patients with brain metastases. No patients were excluded because of "early death," etc., from analysis. All 43 patients received 24-hour DTIC infusions. Do

Successful treatment of good-risk dissem
Successful treatment of good-risk disseminated testicular cancer with cisplatin, bleomycin, and reduced-dose vinblastine
โœ Giorgio Pizzocaro; Roberto Salvioni; Fulvio Zanoni; Angelo Milani; Luigi Piva ๐Ÿ“‚ Article ๐Ÿ“… 1986 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 483 KB ๐Ÿ‘ 2 views

Cisplatin, vinblastine and bleomycin (PVB) is very effective therapy in disseminated testicular cancer, but toxicity is severe. A further reduction of vinblastine might reduce the acute toxicity of PVB without compromising the response rate in good-risk patients. Starting in March 1982, 42 consecuti